questionsmedicales.fr
Thérapeutique
Radiothérapie
Radiothérapie : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Radiothérapie : Questions médicales les plus fréquentes",
"headline": "Radiothérapie : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Radiothérapie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-03",
"dateModified": "2025-04-28",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Radiothérapie"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Thérapeutique",
"url": "https://questionsmedicales.fr/mesh/D013812",
"about": {
"@type": "MedicalCondition",
"name": "Thérapeutique",
"code": {
"@type": "MedicalCode",
"code": "D013812",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Curiethérapie",
"alternateName": "Brachytherapy",
"url": "https://questionsmedicales.fr/mesh/D001918",
"about": {
"@type": "MedicalCondition",
"name": "Curiethérapie",
"code": {
"@type": "MedicalCode",
"code": "D001918",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.150"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chimioradiothérapie",
"alternateName": "Chemoradiotherapy",
"url": "https://questionsmedicales.fr/mesh/D059248",
"about": {
"@type": "MedicalCondition",
"name": "Chimioradiothérapie",
"code": {
"@type": "MedicalCode",
"code": "D059248",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.160"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Chimioradiothérapie adjuvante",
"alternateName": "Chemoradiotherapy, Adjuvant",
"url": "https://questionsmedicales.fr/mesh/D059186",
"about": {
"@type": "MedicalCondition",
"name": "Chimioradiothérapie adjuvante",
"code": {
"@type": "MedicalCode",
"code": "D059186",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.160.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Irradiation crânienne",
"alternateName": "Cranial Irradiation",
"url": "https://questionsmedicales.fr/mesh/D016371",
"about": {
"@type": "MedicalCondition",
"name": "Irradiation crânienne",
"code": {
"@type": "MedicalCode",
"code": "D016371",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.190"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Irradiation hypophysaire",
"alternateName": "Pituitary Irradiation",
"url": "https://questionsmedicales.fr/mesh/D010910",
"about": {
"@type": "MedicalCondition",
"name": "Irradiation hypophysaire",
"code": {
"@type": "MedicalCode",
"code": "D010910",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.190.600"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Irradiation craniospinale",
"alternateName": "Craniospinal Irradiation",
"url": "https://questionsmedicales.fr/mesh/D061888",
"about": {
"@type": "MedicalCondition",
"name": "Irradiation craniospinale",
"code": {
"@type": "MedicalCode",
"code": "D061888",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.230"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Radiothérapie par ions lourds",
"alternateName": "Heavy Ion Radiotherapy",
"url": "https://questionsmedicales.fr/mesh/D063193",
"about": {
"@type": "MedicalCondition",
"name": "Radiothérapie par ions lourds",
"code": {
"@type": "MedicalCode",
"code": "D063193",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.250"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Protonthérapie",
"alternateName": "Proton Therapy",
"url": "https://questionsmedicales.fr/mesh/D061766",
"about": {
"@type": "MedicalCondition",
"name": "Protonthérapie",
"code": {
"@type": "MedicalCode",
"code": "D061766",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.250.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Irradiation hémicorporelle",
"alternateName": "Hemibody Irradiation",
"url": "https://questionsmedicales.fr/mesh/D017619",
"about": {
"@type": "MedicalCondition",
"name": "Irradiation hémicorporelle",
"code": {
"@type": "MedicalCode",
"code": "D017619",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.270"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Irradiation ganglionnaire",
"alternateName": "Lymphatic Irradiation",
"url": "https://questionsmedicales.fr/mesh/D015182",
"about": {
"@type": "MedicalCondition",
"name": "Irradiation ganglionnaire",
"code": {
"@type": "MedicalCode",
"code": "D015182",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.350"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Radioimmunothérapie",
"alternateName": "Radioimmunotherapy",
"url": "https://questionsmedicales.fr/mesh/D016499",
"about": {
"@type": "MedicalCondition",
"name": "Radioimmunothérapie",
"code": {
"@type": "MedicalCode",
"code": "D016499",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.520"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Radiothérapie adjuvante",
"alternateName": "Radiotherapy, Adjuvant",
"url": "https://questionsmedicales.fr/mesh/D018714",
"about": {
"@type": "MedicalCondition",
"name": "Radiothérapie adjuvante",
"code": {
"@type": "MedicalCode",
"code": "D018714",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dosimétrie en radiothérapie",
"alternateName": "Radiotherapy Dosage",
"url": "https://questionsmedicales.fr/mesh/D011879",
"about": {
"@type": "MedicalCondition",
"name": "Dosimétrie en radiothérapie",
"code": {
"@type": "MedicalCode",
"code": "D011879",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.639"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Fractionnement de la dose d'irradiation",
"alternateName": "Dose Fractionation, Radiation",
"url": "https://questionsmedicales.fr/mesh/D019583",
"about": {
"@type": "MedicalCondition",
"name": "Fractionnement de la dose d'irradiation",
"code": {
"@type": "MedicalCode",
"code": "D019583",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.639.200"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hypofractionnement de dose",
"alternateName": "Radiation Dose Hypofractionation",
"url": "https://questionsmedicales.fr/mesh/D000069473",
"about": {
"@type": "MedicalCondition",
"name": "Hypofractionnement de dose",
"code": {
"@type": "MedicalCode",
"code": "D000069473",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.639.200.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Hypofractionnement de dose",
"alternateName": "Radiation Dose Hypofractionation",
"url": "https://questionsmedicales.fr/mesh/D000069473",
"about": {
"@type": "MedicalCondition",
"name": "Hypofractionnement de dose",
"code": {
"@type": "MedicalCode",
"code": "D000069473",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.639.200.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Radiothérapie de haute énergie",
"alternateName": "Radiotherapy, High-Energy",
"url": "https://questionsmedicales.fr/mesh/D011882",
"about": {
"@type": "MedicalCondition",
"name": "Radiothérapie de haute énergie",
"code": {
"@type": "MedicalCode",
"code": "D011882",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.722"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Thérapie par capture de neutrons",
"alternateName": "Neutron Capture Therapy",
"url": "https://questionsmedicales.fr/mesh/D017247",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie par capture de neutrons",
"code": {
"@type": "MedicalCode",
"code": "D017247",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.722.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Thérapie par capture de neutrons par le bore",
"alternateName": "Boron Neutron Capture Therapy",
"url": "https://questionsmedicales.fr/mesh/D016754",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie par capture de neutrons par le bore",
"code": {
"@type": "MedicalCode",
"code": "D016754",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.722.500.100"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Thérapie par capture de neutrons par le bore",
"alternateName": "Boron Neutron Capture Therapy",
"url": "https://questionsmedicales.fr/mesh/D016754",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie par capture de neutrons par le bore",
"code": {
"@type": "MedicalCode",
"code": "D016754",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.722.500.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Télégammathérapie",
"alternateName": "Radioisotope Teletherapy",
"url": "https://questionsmedicales.fr/mesh/D011867",
"about": {
"@type": "MedicalCondition",
"name": "Télégammathérapie",
"code": {
"@type": "MedicalCode",
"code": "D011867",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.722.820"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Radiothérapie guidée par l'image",
"alternateName": "Radiotherapy, Image-Guided",
"url": "https://questionsmedicales.fr/mesh/D061089",
"about": {
"@type": "MedicalCondition",
"name": "Radiothérapie guidée par l'image",
"code": {
"@type": "MedicalCode",
"code": "D061089",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.768"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Radiothérapie X",
"alternateName": "X-Ray Therapy",
"url": "https://questionsmedicales.fr/mesh/D014964",
"about": {
"@type": "MedicalCondition",
"name": "Radiothérapie X",
"code": {
"@type": "MedicalCode",
"code": "D014964",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.907"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Radiothérapie",
"alternateName": "Radiotherapy",
"code": {
"@type": "MedicalCode",
"code": "D011878",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "David R Raleigh",
"url": "https://questionsmedicales.fr/author/David%20R%20Raleigh",
"affiliation": {
"@type": "Organization",
"name": "Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA. David.Raleigh@ucsf.edu."
}
},
{
"@type": "Person",
"name": "Baolin Qu",
"url": "https://questionsmedicales.fr/author/Baolin%20Qu",
"affiliation": {
"@type": "Organization",
"name": "Precision Medical Advanced Innovation Center, Beijing University of Aeronautics and Astronautics, Beijing, 100083."
}
},
{
"@type": "Person",
"name": "Gustavo Arruda Viani",
"url": "https://questionsmedicales.fr/author/Gustavo%20Arruda%20Viani",
"affiliation": {
"@type": "Organization",
"name": "Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (FMRP-USP), Ribeirão Preto, SP, Brazil."
}
},
{
"@type": "Person",
"name": "P A Coucke",
"url": "https://questionsmedicales.fr/author/P%20A%20Coucke",
"affiliation": {
"@type": "Organization",
"name": "Service de Radiothérapie, CHU Liège, Belgique."
}
},
{
"@type": "Person",
"name": "William C Chen",
"url": "https://questionsmedicales.fr/author/William%20C%20Chen",
"affiliation": {
"@type": "Organization",
"name": "Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, 94143, USA. william.chen@ucsf.edu."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Varicella vaccination in India's universal immunisation program -is it time?",
"datePublished": "2022-07-25",
"url": "https://questionsmedicales.fr/article/35880302",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/00494755221107458"
}
},
{
"@type": "ScholarlyArticle",
"name": "Routine Immunization Coverage and Immunization Card Retention in Pakistan: Results From a Cross-sectional National Survey.",
"datePublished": "2023-01-02",
"url": "https://questionsmedicales.fr/article/36728580",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/INF.0000000000003804"
}
},
{
"@type": "ScholarlyArticle",
"name": "Fiscal space for the immunisation program in Zambia- an efficiency analysis approach.",
"datePublished": "2024-06-03",
"url": "https://questionsmedicales.fr/article/38831445",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13104-024-06696-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cost-utility and cost-benefit analysis of pediatric PCV programs in Egypt.",
"datePublished": "2022-09-07",
"url": "https://questionsmedicales.fr/article/36070504",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/21645515.2022.2114252"
}
},
{
"@type": "ScholarlyArticle",
"name": "Childhood immunization and age-appropriate vaccinations in Indonesia.",
"datePublished": "2022-11-05",
"url": "https://questionsmedicales.fr/article/36333713",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12889-022-14408-x"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Thérapeutique",
"item": "https://questionsmedicales.fr/mesh/D013812"
},
{
"@type": "ListItem",
"position": 3,
"name": "Radiothérapie",
"item": "https://questionsmedicales.fr/mesh/D011878"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Radiothérapie - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Radiothérapie",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Radiothérapie",
"description": "Comment la radiothérapie est-elle diagnostiquée ?\nQuels examens précèdent la radiothérapie ?\nQui détermine le besoin de radiothérapie ?\nQuels types de cancers nécessitent la radiothérapie ?\nLa radiothérapie est-elle utilisée en prévention ?",
"url": "https://questionsmedicales.fr/mesh/D011878?mesh_terms=Immunization+Programs&page=7#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Radiothérapie",
"description": "Quels symptômes peuvent apparaître après la radiothérapie ?\nLa radiothérapie cause-t-elle des nausées ?\nY a-t-il des symptômes à long terme ?\nComment gérer la fatigue liée à la radiothérapie ?\nLa radiothérapie affecte-t-elle l'appétit ?",
"url": "https://questionsmedicales.fr/mesh/D011878?mesh_terms=Immunization+Programs&page=7#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Radiothérapie",
"description": "La radiothérapie peut-elle prévenir le cancer ?\nQuels modes de vie aident à prévenir le cancer ?\nLes dépistages aident-ils à éviter la radiothérapie ?\nLes vaccins peuvent-ils prévenir certains cancers ?\nLe stress influence-t-il le cancer ?",
"url": "https://questionsmedicales.fr/mesh/D011878?mesh_terms=Immunization+Programs&page=7#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Radiothérapie",
"description": "Quels types de radiothérapie existent ?\nLa radiothérapie est-elle combinée à d'autres traitements ?\nCombien de séances de radiothérapie sont nécessaires ?\nLa radiothérapie est-elle douloureuse ?\nComment se déroule une séance de radiothérapie ?",
"url": "https://questionsmedicales.fr/mesh/D011878?mesh_terms=Immunization+Programs&page=7#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Radiothérapie",
"description": "Quelles sont les complications possibles de la radiothérapie ?\nLa radiothérapie peut-elle causer des cancers secondaires ?\nComment prévenir les complications de la radiothérapie ?\nLes complications varient-elles selon le type de cancer ?\nQuels soins sont nécessaires après la radiothérapie ?",
"url": "https://questionsmedicales.fr/mesh/D011878?mesh_terms=Immunization+Programs&page=7#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Radiothérapie",
"description": "Quels sont les facteurs de risque pour le cancer traité par radiothérapie ?\nL'âge influence-t-il le besoin de radiothérapie ?\nLes antécédents médicaux influencent-ils la radiothérapie ?\nLe sexe joue-t-il un rôle dans le traitement par radiothérapie ?\nL'alimentation affecte-t-elle le risque de cancer ?",
"url": "https://questionsmedicales.fr/mesh/D011878?mesh_terms=Immunization+Programs&page=7#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment la radiothérapie est-elle diagnostiquée ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "La radiothérapie n'est pas diagnostiquée, mais elle est prescrite après un diagnostic de cancer."
}
},
{
"@type": "Question",
"name": "Quels examens précèdent la radiothérapie ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens d'imagerie comme le scanner ou l'IRM sont souvent réalisés avant la radiothérapie."
}
},
{
"@type": "Question",
"name": "Qui détermine le besoin de radiothérapie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un oncologue est responsable de l'évaluation et de la prescription de la radiothérapie."
}
},
{
"@type": "Question",
"name": "Quels types de cancers nécessitent la radiothérapie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La radiothérapie est couramment utilisée pour les cancers du sein, de la prostate et du poumon."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle utilisée en prévention ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la radiothérapie est un traitement curatif, pas préventif, pour les cancers diagnostiqués."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent apparaître après la radiothérapie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, rougeur de la peau et douleurs localisées selon la zone traitée."
}
},
{
"@type": "Question",
"name": "La radiothérapie cause-t-elle des nausées ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des nausées peuvent survenir, surtout si la zone traitée est l'abdomen ou le cerveau."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes à long terme ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets à long terme peuvent inclure des changements cutanés ou des problèmes de fertilité."
}
},
{
"@type": "Question",
"name": "Comment gérer la fatigue liée à la radiothérapie ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est conseillé de se reposer, de bien s'hydrater et de suivre les conseils du médecin."
}
},
{
"@type": "Question",
"name": "La radiothérapie affecte-t-elle l'appétit ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains patients peuvent éprouver une perte d'appétit pendant le traitement."
}
},
{
"@type": "Question",
"name": "La radiothérapie peut-elle prévenir le cancer ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la radiothérapie est un traitement, pas un moyen de prévention du cancer."
}
},
{
"@type": "Question",
"name": "Quels modes de vie aident à prévenir le cancer ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation saine, l'exercice régulier et l'évitement du tabac peuvent aider à prévenir le cancer."
}
},
{
"@type": "Question",
"name": "Les dépistages aident-ils à éviter la radiothérapie ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dépistages réguliers peuvent détecter le cancer tôt, réduisant ainsi le besoin de radiothérapie."
}
},
{
"@type": "Question",
"name": "Les vaccins peuvent-ils prévenir certains cancers ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des vaccins comme celui contre le HPV peuvent prévenir certains cancers, comme le cancer du col de l'utérus."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il le cancer ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress n'est pas un facteur direct, mais un mode de vie sain peut aider à réduire le risque."
}
},
{
"@type": "Question",
"name": "Quels types de radiothérapie existent ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux types sont la radiothérapie externe et la radiothérapie interne (curiethérapie)."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle combinée à d'autres traitements ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est souvent combinée avec la chimiothérapie ou la chirurgie pour une efficacité accrue."
}
},
{
"@type": "Question",
"name": "Combien de séances de radiothérapie sont nécessaires ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le nombre de séances varie selon le type de cancer, généralement entre 5 et 30 séances."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle douloureuse ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la radiothérapie elle-même n'est pas douloureuse, mais des effets secondaires peuvent l'être."
}
},
{
"@type": "Question",
"name": "Comment se déroule une séance de radiothérapie ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le patient est positionné sur une table, et des rayons ciblés sont administrés sans douleur."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de la radiothérapie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des lésions tissulaires, des infections et des effets secondaires à long terme."
}
},
{
"@type": "Question",
"name": "La radiothérapie peut-elle causer des cancers secondaires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il existe un risque faible de développer des cancers secondaires après une radiothérapie."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications de la radiothérapie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et le respect des recommandations du médecin aident à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon le type de cancer ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent varier selon la localisation et le type de cancer traité."
}
},
{
"@type": "Question",
"name": "Quels soins sont nécessaires après la radiothérapie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des soins de la peau, une bonne hydratation et un suivi médical sont essentiels après le traitement."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour le cancer traité par radiothérapie ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le tabagisme, l'exposition à des substances cancérigènes et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le besoin de radiothérapie ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de cancer augmente avec l'âge, ce qui peut nécessiter une radiothérapie."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils la radiothérapie ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de cancer ou de radiothérapie peuvent influencer le traitement futur."
}
},
{
"@type": "Question",
"name": "Le sexe joue-t-il un rôle dans le traitement par radiothérapie ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines cancers sont plus fréquents chez un sexe, influençant ainsi le besoin de radiothérapie."
}
},
{
"@type": "Question",
"name": "L'alimentation affecte-t-elle le risque de cancer ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en fruits et légumes peut réduire le risque de certains cancers."
}
}
]
}
]
}
We report two representative cases of complicated varicella in immunocompetent children highlighting the significant vaccine preventable varicella burden in the Indian population. A robust surveillanc...
Immunization is one of the most successful public health interventions available, saving millions of lives from death and disability each year. Therefore, improving immunization coverage is a high pri...
The survey was a descriptive cross-sectional national household survey carried out across Pakistan. The survey included 110,790 children 12-23 months old and their caregivers. A World Health Organizat...
Nationally excluding Azad Jammu and Kashmir (AJK) and Gilgit Baltistan (GB), the coverage of fully vaccinated children was 76.5%. The likelihood of being fully vaccinated was higher among children of ...
The immunization coverage rates provide a direction to strategize the progress to improve the vaccination rates in Pakistan. The country needs to outline the immediate and long-term actions to combat ...
The immunisation programme in Zambia remains one of the most effective public health programmes. Its financial sustainability is, however, uncertain. Using administrative data on immunisation coverage...
Out of the 24 districts in our sample, 9 (38%) were technically inefficient in the provision of immunisation services. The average efficiency score, however, was quite high, at 0.92 (CRS technology) a...
New vaccine introductions (NVIs) raise issues of value for money (VfM) for self-financing middle-income countries like Egypt. We evaluate a pediatric pneumococcal conjugate vaccine (PCV) NVI in Egypt ...
Childhood immunization is a cost-effective way to protect individuals against communicable diseases. However, although there is a large literature on childhood immunization in Indonesia, there is a pa...
In this paper, using seven waves of data from the nationally representative Indonesia Demographic and Health Surveys (DHS) covering the period 1991- 2017, we empirically analyse the socio-economic and...
Our findings show that parental education and use of healthcare services are strong predictors of full immunization and age-appropriate vaccinations. This study also finds evidence of spatial heteroge...
Our analysis finds that despite an improvement in the timing of vaccinations over the last two decades, a significant proportion of children continue to receive their measles and DTwP vaccinations age...
In June 2022, French health authorities issued a universal recommendation for routine administration and reimbursement of rotavirus vaccines in infants. Given this recent recommendation by French heal...
A deterministic, age-structured, nonlinear dynamic transmission model, accounting for herd immunity, was developed. We considered 3 vaccination coverage scenarios: high (95%), medium (75%) and low (55...
Over 5 years following implementation, RVGE cases for children under 5 years are estimated to be reduced by 84% under a high vaccination coverage scenario, by 72% under a medium vaccination coverage s...
Rotavirus vaccination with high vaccination coverage in France is expected to substantially reduce the number of RVGE cases and associated healthcare resource utilization....
Influenza vaccines are commonly provided through community health events and primary care appointments. However, acute unscheduled healthcare visits such as emergency department (ED) visits are increa...
We studied an ED-based influenza vaccination initiative in an urban hospital and examined patient-level factors associated with screening and vaccination uptake. Our analyses included patient visits t...
The influenza screening and vaccination program proved feasible. Of the 20,878 ED visits that occurred within the study period, 3,565 (17.1%) included a screening for influenza vaccine eligibility; a ...
Vaccination programs in the ED can boost community vaccination rates and play a role in both preventing and treating current and future vaccine-preventable public health crises, although efforts must ...
The most common preventative measure against mumps is vaccination with mumps vaccine. Over 122 countries have implemented mumps vaccine routine immunization programs, mostly via Measles-Mumps-Rubella ...
We conducted cost-effectiveness analyses with Markov model and calculated incremental cost-effectiveness ratios (ICERs) of two different vaccination programs (a single-dose program at one-year-old, a ...
Both programs reduce disease treatment costs compared to status quo, while the reduction cannot offset vaccination cost. ICER of either program is found to be under ¥5,000,000 (US$47,170)/QALY willing...
Routine vaccination program of single- and two-dose programs were cost-effective from both payers' and societal perspectives. Between the two, the two-dose vaccination program was observed to be more ...
The Malaita and Western provinces in Solomon Islands had low routine immunization coverage due to disruptions in health services caused by the coronavirus disease 2019 pandemic in early 2022....
The country introduced the World Health Organization (WHO) Reaching Every District (RED) approach in 2002. Between July and September 2022, we strengthened supportive supervision, monitoring and use o...
Solomon Islands' population is 748 606 people, of whom 165 345 reside in Malaita and 105 367 in Western Province....
In Malaita Province, reported coverage of third dose of pentavalent vaccine and first dose of measles-rubella vaccine increased from 40% (757/1892) of eligible children to 121% (1144/946) and from 30%...
Supportive supervision, systematic monitoring and use of data for decision-making helped restoring reported immunization coverage in two low-coverage provinces. However, sustaining these results at a ...
The increasing number of vaccines and the complexity of immunization programs, along with continuous changes in the epidemiology of infectious diseases, necessitate a systematic approach to vaccine ef...
Experts' opinions were collected through a two-round online survey targeting key stakeholders. The first round consisted of two multiple-choice questions and two open-ended questions. The second round...
The results emphasize the necessity and urgency of a government-led VE evaluation system and the establishment of a multidisciplinary evaluation organization. Key considerations include personnel, bud...
These findings provide valuable insights for policymakers, emphasizing the need for collaboration, financial support, and robust data management in developing evidence-based vaccination policies....